...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AACR 2018
2
Jan 18, 2018 04:07PM
5
Feb 21, 2018 11:38AM
3
Feb 21, 2018 05:45PM
4
Feb 21, 2018 05:52PM
5
Feb 22, 2018 10:34AM
4
Feb 22, 2018 02:25PM
3
Feb 23, 2018 02:54AM
3
Feb 23, 2018 11:14AM
3
Feb 23, 2018 12:41PM
3
Feb 27, 2018 06:33PM
1
Feb 27, 2018 08:43PM
4
Feb 28, 2018 10:42AM
2
Feb 28, 2018 05:41PM
3
Feb 28, 2018 05:57PM
2
Mar 01, 2018 05:17PM
2
Mar 01, 2018 09:35PM
1
Mar 05, 2018 03:13PM
2
Mar 05, 2018 03:59PM
2
Mar 05, 2018 11:08PM
3
Mar 06, 2018 03:46AM
2
Mar 06, 2018 10:13AM
2
Mar 06, 2018 01:15PM
2
Mar 06, 2018 01:24PM

Late Breaking and Clinical Trial abstract titles for AACR were posted last week. I didn't see any titles for Zenith. I inquired with Clayton and he stated that Zenith will not be presenting an abstract at AACR. Also, the full Asangani abstract is now posted, but no meniton of Zenith despite him listing Zenith in his disclosures.

3
Apr 13, 2018 09:23AM
Share
New Message
Please login to post a reply